Top Markets
#1 Bedrock Bedrock +42.69%
#2 Talus Network Talus Network +24.65%
#3 API3 API3 +20.65%
#4 CyberDEX CyberDEX +19.21%
#5 iExec RLC iExec RLC +18.52%
#6 Radicle Radicle +16.37%
#7 The Bitcoin Bull The Bitcoin Bull +16.37%
#8 VeThor VeThor +13.05%
#9 Verus Coin Verus Coin +11.08%
#10 Rollbit Coin Rollbit Coin +10.44%
Coin of the day
Bedrock Bedrock
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cell Source, Inc. Cell Source, Inc.

Cell Source, Inc.

CLCS
Rangering i aksjer #28220
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based... Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system management technology, an advanced immune tolerance platform capable of selectively suppressing specific immune responses. This Veto Cell technology finds application in numerous areas, including enhancing the acceptance of stem cell transplants for conditions like lymphoma, leukemia, and multiple myeloma. Furthermore, it is utilized in treating end-stage kidney disease, various other non-malignant organ diseases, and a spectrum of both cancerous and non-malignant illnesses. Founded in 2012, Cell Source, Inc. maintains its corporate headquarters in New York, New York.
Aksjekurs
$0.4
Sist synkronisert: 2026-10-02
Markedsverdi
$27.18M
Endring (1 dag)
-14.88%
Endring (1 år)
8.11%
Land
US
Handel Cell Source, Inc. (CLCS)

Kategori

Healthcare
P/S-forhold for Cell Source, Inc. (CLCS)
P/S-forhold per 2026 TTM: 0
Ifølge Cell Source, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Cell Source, Inc. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.51 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
34.29 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.77 -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
11.49 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH